She, J., Chen, X., Iyengar, M., & Li, J. (2026). Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review.
Style de citation Chicago (17e éd.)She, Jane, Xiaofei Chen, Malini Iyengar, et Judy Li. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.
Style de citation MLA (9e éd.)She, Jane, et al. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.
Attention : ces citations peuvent ne pas être correctes à 100%.